PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
10877926-7	2000	The remaining rotational behavior seen after grafting was studied and recordings were performed in the striatum following systemic injection of the D1/D2 agonist apomorphine.	Apomorphine	162-173	leiomodin 1	Homo sapiens	148-153	
8787038-5	1995	The aim of this study was to compare the affinities of bromocriptine, lisuride, pergolide, and apomorphine for the D1, D2, and D3 receptors in postmortem human striatum.	Apomorphine	95-106	leiomodin 1	Homo sapiens	115-139	
10880821-6	2000	Additionally, clinical research with apomorphine, a D1/D2 agonist, has shown significant promise in improving erections in men with a wide range of erectile difficulties.	Apomorphine	37-48	leiomodin 1	Homo sapiens	52-57	
1387376-11	1992	It may be concluded that pecking, induced by apomorphine in pigeons, is elicited through activation of both D-1 and D-2 dopamine-receptors.	Apomorphine	45-56	leiomodin 1	Homo sapiens	108-119	
23840482-3	2013	Here we adopt the alternative approach: we manipulate dopamine activity using apomorphine (D1/D2 agonist) and measure the change in neurological indices of novelty processing.	Apomorphine	78-89	leiomodin 1	Homo sapiens	91-96	
19837701-2	2009	Apomorphine is a potent short-acting D1/D2 dopamine agonist administered sub-cutaneously that is used in the treatment of PD.	Apomorphine	0-11	leiomodin 1	Homo sapiens	37-42	
15549138-9	2005	In conclusion, we show that (1) apomorphine has a peripheral relaxant direct effect as well as an antiadrenergic activity, (2) HCC possesses more D1-like (D1 and D5) than D2-like (D2, D3 and D4) receptors, (3) both D1- and D2-like receptors are mainly localized on smooth muscle cells and (4) the relaxant activity is most probably mediated by D1-like receptor partially through NO release from endothelium.	Apomorphine	32-43	leiomodin 1	Homo sapiens	146-164	
22291240-1	1992	A comparison of the effects of apomorphine, amphetamine and dopamine (DA) receptor subtype-specific agonists in responding for conditioned reward, self-administration and place conditioning paradigms provides insights into the possible involvement of D-1 and D-2 receptors in reward-related learning.	Apomorphine	31-42	leiomodin 1	Homo sapiens	251-272	
1832988-0	1991	Effects of D1 and D2 antagonists on apomorphine-induced responses of ventral pallidal neurons.	Apomorphine	36-47	leiomodin 1	Homo sapiens	11-20	
1832988-3	1991	The present studies evaluated the contribution of D1 and D2 receptor subtypes to apomorphine-induced alterations in extracellularly recorded VP neuronal activity.	Apomorphine	81-92	leiomodin 1	Homo sapiens	50-59